Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]

Allan Rodriguez; Christina Hill-Zabala; Louis Sloan; Thomas Jefferson; Linda Yau; Maria Watson; David Irlbeck; Mark Shaefer

doi:10.1097/01.qai.0000191999.77658.6e

Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]

Allan Rodriguez, Christina Hill-Zabala, Louis Sloan, Thomas Jefferson, Linda Yau, Maria Watson, David Irlbeck, Mark Shaefer

Medicine

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	127-129
Number of pages	3
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	41
Issue number	1
DOIs	https://doi.org/10.1097/01.qai.0000191999.77658.6e
State	Published - Jan 1 2006

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Access to Document

10.1097/01.qai.0000191999.77658.6e

Cite this

Rodriguez, A., Hill-Zabala, C., Sloan, L., Jefferson, T., Yau, L., Watson, M., Irlbeck, D., & Shaefer, M. (2006). Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]. Journal of Acquired Immune Deficiency Syndromes, 41(1), 127-129. https://doi.org/10.1097/01.qai.0000191999.77658.6e

Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]. / Rodriguez, Allan; Hill-Zabala, Christina; Sloan, Louis; Jefferson, Thomas; Yau, Linda; Watson, Maria; Irlbeck, David; Shaefer, Mark.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 41, No. 1, 01.01.2006, p. 127-129.

Research output: Contribution to journal › Letter › peer-review

Rodriguez, A, Hill-Zabala, C, Sloan, L, Jefferson, T, Yau, L, Watson, M, Irlbeck, D & Shaefer, M 2006, 'Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]', Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 1, pp. 127-129. https://doi.org/10.1097/01.qai.0000191999.77658.6e

Rodriguez A, Hill-Zabala C, Sloan L, Jefferson T, Yau L, Watson M et al. Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]. Journal of Acquired Immune Deficiency Syndromes. 2006 Jan 1;41(1):127-129. https://doi.org/10.1097/01.qai.0000191999.77658.6e

Rodriguez, Allan ; Hill-Zabala, Christina ; Sloan, Louis ; Jefferson, Thomas ; Yau, Linda ; Watson, Maria ; Irlbeck, David ; Shaefer, Mark. / Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]. In: Journal of Acquired Immune Deficiency Syndromes. 2006 ; Vol. 41, No. 1. pp. 127-129.

@article{b2675dfb17794775b70b847d66652f06,

title = "Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]",

author = "Allan Rodriguez and Christina Hill-Zabala and Louis Sloan and Thomas Jefferson and Linda Yau and Maria Watson and David Irlbeck and Mark Shaefer",

year = "2006",

month = jan,

day = "1",

doi = "10.1097/01.qai.0000191999.77658.6e",

language = "English (US)",

volume = "41",

pages = "127--129",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "1",

}

TY - JOUR

T1 - Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]

AU - Rodriguez, Allan

AU - Hill-Zabala, Christina

AU - Sloan, Louis

AU - Jefferson, Thomas

AU - Yau, Linda

AU - Watson, Maria

AU - Irlbeck, David

AU - Shaefer, Mark

PY - 2006/1/1

Y1 - 2006/1/1

UR - http://www.scopus.com/inward/record.url?scp=28944437873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28944437873&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000191999.77658.6e

DO - 10.1097/01.qai.0000191999.77658.6e

M3 - Letter

C2 - 16340487

AN - SCOPUS:28944437873

VL - 41

SP - 127

EP - 129

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -

Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine analogue and lamivudine can be successfully treated with a quadruple-nucleoside regimen [3]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this